17 results
8-K
EX-10.1
RGLS
Regulus Therapeutics Inc
14 Mar 24
Regulus Therapeutics Announces Oversubscribed $100 Million Private Placement of Equity
4:57pm
of any controversy that may arise with respect to the interpretation or implementation of this Agreement.
6.6 (a) To the extent permitted by law
8-K
EX-99.1
RGLS
Regulus Therapeutics Inc
13 Apr 23
Securities Purchase Agreement
4:05pm
to restrain, enjoin or otherwise delay any registration pursuant to Section 6.1 hereof as a result of any controversy that may arise with respect
8-K
EX-99.1
RGLS
Regulus Therapeutics Inc
30 Nov 21
Securities Purchase Agreement
5:27pm
to Section 6.1 hereof as a result of any controversy that may arise with respect to the interpretation or implementation of this Agreement.
6.6
424B5
RGLS
Regulus Therapeutics Inc
10 Aug 21
Prospectus supplement for primary offering
4:02pm
in the applicable prospectus supplement, the warrants and warrant agreements, and any claim, controversy or dispute arising under or related
8-K
EX-10.1
70dwqkj 7n
4 Dec 20
Regulus Therapeutics Announces Private Placement of Equity
4:18pm
8-K
EX-10.1
hw7 0jmss04j
9 May 19
Regulus Therapeutics Announces Private Placement of Equity
5:16pm
8-K
EX-99.3
a87gp p0w3
5 Feb 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
3w83ot qux0
11 Oct 12
Entry into a Material Definitive Agreement
12:00am
- Prev
- 1
- Next